Inovio Pharmaceuticals, Inc. logo

Inovio Pharmaceuticals, Inc.

NASDAQ:INO

Overview | Financials
Company Name Inovio Pharmaceuticals, Inc.
Symbol INO
Currency USD
Price 6.81
Market Cap 176,816,883
Dividend Yield 0%
52-week-range 3.84 - 14.75
Industry Biotechnology
Sector Healthcare
CEO Dr. Jacqueline E. Shea Ph.D.
Website https://www.inovio.com

An error occurred while fetching data.

About Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target

Related Stocks

IDEAYA Biosciences, Inc. logo

IDEAYA Biosciences, Inc.

IDYA

37.46 USD

Accolade, Inc. logo

Accolade, Inc.

ACCD

4.26 USD

MiMedx Group, Inc. logo

MiMedx Group, Inc.

MDXG

6.22 USD

Agenus Inc. logo

Agenus Inc.

AGEN

6.26 USD

Centessa Pharmaceuticals plc logo

Centessa Pharmaceuticals plc

CNTA

16.99 USD

Leafly Holdings, Inc. logo

Leafly Holdings, Inc.

LFLY

1.8 USD

Tarsus Pharmaceuticals, Inc. logo

Tarsus Pharmaceuticals, Inc.

TARS

33.26 USD

AxoGen, Inc. logo

AxoGen, Inc.

AXGN

13.79 USD

Financials

Numbers are in millions USD

Numbers are in millions USD